GP Training | Catalogue


	GP Training - Catalogue Gastroenterology: Total learning time 6 hours Module 1: GORD – Therapy with PPI for moderate-to-severe disease and complications Oesophageal disease is one of the most common chronic problems managed in general practice. Proton pump inhibitors (PPIs) are first line therapy for GORD because they offer rapid symptom relief and oesophageal healing resulting in lower total drug and consultation costs. This online learning module uses a case-based approach to review gastro-oesophageal reflux disease (GORD) in particular therapy with proton pump inhibitors for moderate-to-severe disease and complications. Meet Kevin, a 53-year-old male prescribed a PPI for intermittent heart burn and acid reflux (3–4 times per week). Within a day or two of the last pill, Kevin began to experience epigastric pain, burning sensation, and acid taste in his mouth. He had occasional choking episodes at night. Since his wife left him he has been gaining weight and drinking and smoking with his mates more than usual. Review treatment protocols and patient management options based on expert opinion and the latest evidence. At the conclusion of this online learning module you will be able to: Understand the presentation and management of moderate-to-severe GORD Diagnose and treat oesophageal strictures Diagnose and treat of Barrett’s oesophagus and its role as a precursor to oesophageal adenocarcinoma. Understand the role Helicobacter pylori may play in Barrett’s oesophagus and patient safety. Module 2: Colorectal cancer screening—who, when, and how Colorectal cancer is a growing problem in Australia. Screening protocols are constantly being revisited as more information becomes available about the utility of the various available screening modalities. The busy GP needs to be able to counsel his or her patient armed with the most up-to-date recommendations. This online learning module extends a GP’s knowledge about colorectal cancer screening—who, when and how. Jane is a 55-year-old woman, quite overweight, presenting with weight loss and diarrhoea with cramps. Her GP puts the diarrhoea down to over-indulgence and implies that Jane should be happy that she has shed a couple of kilos. Learn about the current GESA screening guidelines and be prepared to implement them in appropriate patients. Review treatment protocols and patient management options based on expert opinion and the latest evidence. At the conclusion of this online learning module you will be able to: Recognise potential signs and symptoms of colorectal cancer (CRC). Identify patients at risk for CRC. Describe current screening recommendations. Outline risks and benefits of various screening modalities. Module 3: It's Not Always the Grog Non-alcoholic fatty liver disease or NAFLD represents a spectrum of disorders in which fat deposits are seen in the liver, even if patients don’t drink what are considered to be harmful amounts of alcohol. In this online learning module fatty liver resulting from metabolic factors is discussed. Anne, a 55-year-old woman has returned for test results. She had requested the testing because she has just changed doctors, is overweight, and knows she has to start doing something about her weight and lifestyle. Anne has some markers of the metabolic syndrome (elevated cholesterol, insulin resistance, hypertension, and abdominal obesity) Anne’s liver enzymes are also somewhat elevated; she denies excess alcohol consumption, illegal substance abuse, hepatitis, and a family history of liver disease. Further tests needed to determine the cause of Anne’s elevated liver enzymes. Review treatment protocols and patient management options based on expert opinion and the latest evidence. At the conclusion of this online learning module you will be able to: Appreciate the pathophysiology of non-alcoholic fatty liver disease/ non-alcoholic steatohepatitis (NAFLD/NASH). Distinguish NAFLD from other causes of fatty liver. Develop a diagnostic approach to NAFLD/NASH Know how to manage NAFLD/NASH. Module 4: Unusual gastrointestinal presentations: cracking the tough cases On occasion, the patient who presents with abdominal pain along with vomiting, diarrhoea, or constipation doesn’t have a stomach bug or irritable bowel syndrome. In this module we look at several gastrointestinal cases that will require you to think outside the box a little differently. Several case studies covering abdominal pain and emesis, biliary tract, pancreatic, and salivary gland disease; abdominal pain, paraesthesias, and pruritus; a 4-year-old boy with vomiting and diarrhoea and constipation and general malaise are presented. Review treatment protocols and patient management options based on expert opinion and the latest evidence. At the conclusion of this online learning module you will be able to: Recognise and treat the paediatric patient with asymptomatic gallstones Recognise and treat autoimmune chronic pancreatitis Recognise and treat Choledochal cysts Recognise and treat acute iron poisoning Recognise and treat ciguatera fish poisoning. Module 5: Inflammatory Bowel Disease—A New Look at an Old Enemy Inflammatory bowel disease (IBD) actually comprises two distinct disorders—ulcerative colitis and Crohn’s disease—that have different pathological and clinical characteristics. In this online learning module we look at the journey of a patient with IBD. Vicky is a 24 year-old teacher with a 4–5 week history of intermittent bloody diarrhoea, rectal urgency, and occasional cramping. Diarrhoea began during trip to India and Nepal. Current medications include an oral contraceptive; she uses NSAIDs prophylactically around time of monthly period and claims to have a healthy diet. She admits to being a social drinker; non-smoker and does not report fever or weight loss. Review treatment protocols and patient management options based on expert opinion and the latest evidence. At the conclusion of this online learning module you will be able to: Differentiate between ulcerative colitis and Crohn’s disease according to their underlying pathology Describe the signs and symptoms of ulcerative colitis and Crohn’s disease Offer patients appropriate counseling regarding the risk of colorectal cancer and fertility issues in IBD Discuss treatment options for ulcerative colitis and Crohn’s disease. Module 6: Coeliac disease—not just a dietary disorder Coeliac disease is an autoimmune disease affecting around one percent of Australians. Caused by exposure to gluten, it results in chronic inflammation of the lining of the intestine. Among patients with silent or latent disease, the diagnosis is likely to be missed. Thus, clinicians need to have a high index of suspicion in patients who have associated conditions such as anaemia, herpetiformis dermatitis, and Type 1 diabetes. Review treatment protocols and patient management options based on expert opinion and the latest evidence. Ongoing monitoring and counselling is essential to promote adherence to the gluten-free diet. At the conclusion of this online learning module you will be able to: Identify the signs and symptoms of coeliac disease Understand the long term risks associated with coeliac disease Discuss the underlying pathophysiology of coeliac disease and the role of dietary restrictions with patients. Recognise and treat patients who need more aggressive therapy.
	Managing metabolic syndrome: Total learning time 6 hours
	Smoking Cessation: Total learning time 2 hours per module
	Clinical update: Sertraline - Total learning time 2 hours per module
	Major Depression: relative efficacy in antidepressant therapy. - Total learning time 2 hours per module
	Smoking Cessation: APNA endorsed - 1 hour per module
	Migraine Management in General Practice: Total learning time 2 hours per module
	Osteoporosis: Total learning time 6 hours
	Bipolar: Total learning time 6 hours
	Non-hormonal treatment of menorrhagia: Total learning time 2 hours per module
	Obesity Management: Total learning time 6 hours
	Obesity Management: APNA endorsed - 1 hour per module

register to access health courses training

GP Training - Catalogue